Mednow Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Simranveer Grewal
- Full Time Employees
- 100
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 595 Howe St. Vancouver BC Canada V6C 2T5
- IPO Date
- Jul 9, 2021
- Website
- mednow.ca
- Similar Companies
- Business
- Mednow Inc. (TSXV: MNOW; OTCQX: MDNWF) operates as a Canada-based healthcare technology company focused on virtual pharmacy, telemedicine, and related services to enhance patient access and care. Founded in 2018 and headquartered in Toronto, Ontario, the company provides a proprietary web and mobile platform enabling prescription uploads, transfers, refills, and free nationwide delivery of medications including inhalers, creams, and injectables; its signature PillSmart system packages prescriptions into labeled daily dose packs at no extra cost; virtual consultations with pharmacists and clinicians for common ailments, medication reviews, and optimizations; direct billing to private insurers and provincial plans in British Columbia and Ontario; and additional offerings such as home doctor visits, diabetes management programs, and wellness products like vitamin packs. Mednow also owns and operates retail pharmacies in British Columbia and Ontario, previously integrated subsidiaries including InfusiCare for specialty biologics and London Pharmacare for clinical services, and targets patients, caregivers, seniors, and providers across Canada with an emphasis on convenience, adherence, and interdisciplinary care. Recent developments include a December 2024 partnership with Integracare Inc. to bolster home healthcare for aging Canadians through integrated medication management, adherence support, and in-home services; a major technology update launching caregiver-focused features for multi-patient management; completion of the InfusiCare Canada acquisition in early 2025 to expand biologic drug capabilities and same-day delivery; and ongoing strategic shifts such as winding down select subsidiaries to streamline operations.
Mednow Restructuring to Meet Long-Term Needs of Stakeholders
Mednow Announces Notice Received From Secured Creditor and Plan to Work on a Transitional Plan
Mednow Announces Corporate Update
Mednow Announces Closing of Senior Secured Convertible Debenture Financing by Mednow Management
Mednow Announces Corporate Update
Mednow Announces an Update on the Wind-Down of a Subsidiary
Mednow Announces the Execution of Cost Reductions Through the Wind-Down of a Subsidiary
Mednow Announces Senior Secured Convertible Debenture Financing by Mednow Management
Mednow Announces Board Member Resignations
Mednow Announces the Execution of Cost Reductions Through the Wind-Down of Two Subsidiaries
Mednow Announces Closing of Senior Secured Convertible Debenture Financing by Mednow Management
Mednow Announces Senior Secured Convertible Debenture Financing by Mednow Management
Mednow Inc. to Present at LD Micro Invitational XIII
Mednow Inc. to Present at the Gravitas' 4th Los Angeles Summit
Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom
Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results
Mednow says it is officially open to serve patients in Quebec, with its newest location serving as its pharmacy distribution center
Mednow disrupts the Canadian drug market as a virtual pharmacy and telemedicine powerhouse
Mednow subsidiary partners with non-profit company HepCURE to help eliminate hepatitis C in Canada by 2030
Mednow beats guidance with record 3Q results and announces Ali Reyhany as CEO